# Abbott Laboratories (ABT) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $8.05B |
| 2024 | $6.83B |
| 2023 | $6.48B |
| 2022 | $8.36B |
| 2021 | $8.43B |
| 2020 | $5.36B |
| 2019 | $4.53B |
| 2018 | $3.65B |
| 2017 | $1.56B |
| 2016 | $3.03B |
| 2015 | $2.87B |
| 2014 | $2.60B |
| 2013 | $2.13B |
| 2012 | $1.36B |
| 2011 | $1.63B |
| 2010 | $6.09B |
| 2009 | $6.24B |
| 2008 | $5.69B |
| 2007 | $4.58B |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $1.34B |
| 2025-09-30 | $2.06B |
| 2025-06-30 | $2.05B |
| 2025-03-31 | $1.69B |
| 2024-09-30 | $1.86B |
| 2024-06-30 | $1.67B |
| 2024-03-31 | $1.39B |
| 2023-09-30 | $1.65B |
| 2023-06-30 | $1.54B |
| 2023-03-31 | $1.51B |
| 2022-09-30 | $1.77B |
| 2022-06-30 | $2.38B |
| 2022-03-31 | $2.91B |
| 2021-09-30 | $2.55B |
| 2021-06-30 | $1.39B |
| 2021-03-31 | $2.11B |
| 2020-09-30 | $1.50B |
| 2020-06-30 | $672M |
| 2020-03-31 | $758M |
| 2019-09-30 | $1.20B |
| 2019-06-30 | $1.21B |
| 2019-03-31 | $739M |
| 2018-09-30 | $995M |
| 2018-06-30 | $882M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ABT/operating-income)